IBD treatment and frailty in patients over 60
Part of Digestive system clinical trials.
This study looks at how inflammatory bowel disease (IBD) activity affects frailty in people over 60. It tests whether starting or changing medication for active IBD can help understand and manage frailty.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 60 years or older.
- You must have Crohn's disease or ulcerative colitis (confirmed by a doctor).
- You need to start a new medication (like oral mesalazine, steroids, immunosuppressants, or biologics) because your IBD is active.
- Your IBD activity must be shown by symptoms or lab tests (like high fecal calprotectin or C-reactive protein).
- You cannot have an ostomy (a bag for waste).
- You cannot change medication only because of side effects.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at people with Crohn's disease or ulcerative colitis who have already tried and failed at least one advanced medication (like a biologic or small molecule drug). If you are starting a new advanced therapy, researchers will track how well it works for you.
This study is looking at how common osteoporosis is in people with inflammatory bowel disease (like Crohn's or colitis). It will help doctors understand if bone health screening should be a bigger priority for IBD patients.
This study tests whether adding a diet and stress management program to standard advanced therapy helps people with active Crohn's disease or ulcerative colitis feel better. It combines lifestyle changes with new medications to improve treatment outcomes.
This study looks at changes in fats (lipids) in the blood and the lining of the gut in people with inflammatory bowel disease (IBD). It may help researchers understand IBD better and find new ways to treat it.
This study looks at whether gut bacteria (intestinal flora) are linked to frailty in people age 65 and older. It will also test an intervention to see if changing gut bacteria can help reduce frailty.
This study tests whether it is safe to stop taking acid-reducing pills (PPIs) for people with inactive IBD. If you have been on a PPI for over 6 months and your IBD is stable, you may be able to join.
Hear when a new IBD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.